Chemed CHE Q1 2026 Beat Revenue NA EPS Exceeds by Significant Molina Healthcare MOH Stock Down 195 Support Test at 17881 20260514 Micware Co Ltd Prices Upsized Initial Public Offering of American Depositary Shares Mistras Group MG Drops 261 Key Support at 1592 20260519 CG Oncology CGON Q1 2026 Underwhelms Revenue Pressure Hits Bottom Line Saab Eyes Expanded Role in Japans Defense Modernization Push HALO Stocks Emerge as a Hot Market Theme as Investors Seek Assets AI Cannot Replace Meta Initiates Fresh Round of Layoffs Amid AI Transformation Eliminating 8000 Roles Deel Expands Payroll Options with Stablecoin Salary Payouts Disney Shares Surge 7 After Streaming and Parks Drive Revenue Beat in First Earnings Report Under CEO Josh DAmaro RBI Policy Shift Raises Questions on Framework Consistency Nomura Suggests Vickers Top Insider Picks Report Released for May 27 2026 AIDriven Drug Discovery Could Accelerate Treatments for Brain Conditions Like MND Dating Startups Target Fake Profiles as User Trust Becomes Critical EQPT Q1 2026 Earnings EPS Beat Drives 41 Stock Rally Mount Logan Capital Inc Q1 2026 Earnings Net Loss Reported Amid Strategic Positioning KRG Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Holds Steady ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher PCG Q1 2026 Earnings Earnings Beat Expectations on Solid Operational Performance Marine Products Corporation MPX Q1 2026 Earnings Weak Profitability and Stock Decline Highlight Ongoing Challenges ARAY Q1 2026 Earnings EPS Misses Estimates Stock Surges Despite WiderThanExpected Loss RIME Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Prairie Operating Co PROP Q1 2026 Earnings Wide EPS Miss Amid No Revenue FTI Q1 2026 Earnings EPS Surges Past Estimates Despite Stock Dip NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline Why PureTech PRTC could deliver where others fall short Overhead Buying 20260511 The Hidden Pitfall of the 4 Rule Why Retirees May Need to Rethink Withdrawal Strategies MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline